Bacteriologic analysis of infected dog and cat bites

New England Journal of Medicine

Volumn 340, Issue 2, 1999, Pages 85-92

  Talan, David A ^a   Citron, Diane M ^b   Abrahamian, Fredrick M ^c   Moran, Gregory J ^a   Goldstein, Ellie J C ^b  

^a OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^b Santa Monica UCLA Medical Center   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEFAZOLIN; CEFOTAXIME; CEFTRIAXONE; CLAVULANIC ACID; CLINDAMYCIN; DICLOXACILLIN; DOXYCYCLINE; GENTAMICIN; LORACARBEF; PENICILLIN G; SULBACTAM;

ABSCESS; ADOLESCENT; ADULT; AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; BITE WOUND; CAT; CHILD; CONTROLLED STUDY; DOG BITE; FEMALE; FEVER; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LABORATORY DIAGNOSIS; LYMPHANGITIS; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; ORAL DRUG ADMINISTRATION; PASTEURELLA; PRIORITY JOURNAL; WOUND INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA, AEROBIC; BACTERIA, ANAEROBIC; BETA-LACTAMASES; BETA-LACTAMS; BITES AND STINGS; CATS; CHILD; CHILD, PRESCHOOL; DOGS; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; PASTEURELLA; PROSPECTIVE STUDIES; WOUND INFECTION;

EID: 0033552854     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199901143400202     Document Type: Article

References (43)

1. Weiss HB, Friedman DI, Coben JH. Incidence of dog bite injuries treated in emergency departments. JAMA 1998;279:51-3.
2. Lauer EA, White WC, Lauer BA. Dog bites: a neglected problem in accident prevention. Am J Dis Child 1982;136:202-4.
3. Douglas LG. Bite wounds. Am Fam Physician 1975;11:93-9.
4. Aghababian RV, Conte JE Jr. Mammalian bite wounds. Ann Emerg Med 1980;9:79-83.
5. Thomas PR, Buntine JA. Man's best friend? A review of the Austin Hospital's experience with dog bites. Med J Aust 1987;147:536-40.
6. Elenbaas RM, McNabney WK, Robinson WA. Evaluation of prophylactic oxacillin in cat bite wounds. Ann Emerg Med 1984;13:155-7.
7. Feder HM Jr, Shanley JD, Barbera JA. Review of 59 patients hospital ized with animal bites. Pediatr Infect Dis J 1987;6:24-8.
8. Elliot DL, Tolle SW, Goldberg L, Miller JB. Pet-associated illness. N Engl J Med 1985;313:985-95.
9. Callaham ML. Prophylactic antibiotics in common dog bite wounds: a controlled study. Ann Emerg Med 1980;9:410-4.
10. Idem. Treatment of common dog bites: infection risk factors. JACEP 1978;7:83-7.
11. Skurka J, Willert C, Yogev R. Wound infection following dog bite despite prophylactic penicillin. Infection 1986;14:134-5.
12. Jones DA, Stanbridge TN. A clinical trial using co-trimoxazole in an attempt to reduce wound infection rates in dog bite wounds. Postgrad Med J 1985;61:593-4.
13. Cummings P. Antibiotics to prevent infection in patients with dog bite wounds: a meta-analysis of randomized trials. Ann Emerg Med 1994;23: 535-40.
14. Goldstein EJC, Citron DM, Wield B, et al. Bacteriology of human and animal bite wounds. J Clin Microbiol 1978;8:667-72.
15. Brook I. Microbiology of human and animal bite wounds in children. Pediatr Infect Dis J 1987;6:29-32.
16. Weber DJ, Wolfson JS, Swartz MN, Hooper DC. Pasteurella multocida infections: report of 34 cases and review of the literature. Medicine (Baltimore) 1984;63:133-54.
17. Lion C, Escande F, Burdin JC. Capnocytophaga canimorsus infections in human: review of the literature and cases report. Eur J Epidemiol 1996; 12:521-33.
18. Bracis R, Seibers K, Julien RM. Meningitis caused by group II J following a dog bite. West J Med 1979;131:438-40.
19. Talan DA, Staatz D, Staatz A, Goldstein EJC, Singer K, Overturf GD. Staphylococcus intermedius in canine gingiva and canine-inflicted human wound infections: laboratory characterization of a newly recognized zoonotic pathogen. J Clin Microbiol 1989;27:78-81.
20. Murray PR, ed. Manual of clinical microbiology. 6th ed. Washington, D.C.: ASM Press, 1995.
21. Summanen P, Baron EJ, Citron DM, Strong CA, Wexler HM, Finegold SM. Wadsworth anaerobic bacteriology manual 5th ed. Belmont, Calif.: Star Publishing, 1993.
22. Holt JG, Kreig R, Sneath PHA, Staley JT, Williams ST. Bergey's manual of determinative bacteriology. 9th ed. Baltimore: Williams & Wilkins, 1994.
23. Weyant RS, Moss CW, Weaver RE, et al. Identification of unusual pathogenic gram-negative and aerobic and facultatively anaerobic bacteria. 2nd ed. Baltimore: Williams & Wilkins, 1996.
24. Holdeman LV, Cato P, Moore WEC. Anaerobe lab manual. 4th ed. Blacksberg: Virginia Polytechnic Institute and State University, 1997.
25. Hudspeth MK, Gerardo SH, Citron DM, Goldstein EJC. Growth characteristics and a novel method for identification (the WEE-TAB system) of Porphyromonas species isolated from infected dog and cat bite wounds in humans. J Clin Microbiol 1997;35:2450-3.
26. Alexander CJ, Citron DM, Gerardo SH, Claros MC, Talan D, Goldstein EJC. Characterization of saccharolytic Bacteroides and Provotella isolates from infected dog and cat bite wounds in humans. J Clin Microbiol 1997;35:406-11.
27. Citron DM, Gerardo SH, Claros MC, Abrahamian F, Talan DA, Goldstein EJC. Frequency of isolation of Porphyromonas species from infected dog and cat bite wounds in humans and their characterization by biochemical tests and arbitrarily primed-polymerase chain reaction fingerprinting. Clin Infect Dis 1996;23:Suppl 1:S78-S82.
28. Baron EJ, Strong CA, McTeague M, Vaisanen M-L, Finegold SM. Survival of anaerobes in original specimens transported by overnight mail services. Clin Infect Dis 1995;20:Suppl 2:S174-S177.
29. Bailie WE, Stowe EC, Schmitt AM. Aerobic bacterial flora of oral and nasal fluids of canines with reference to bacteria associated with bites. J Clin Microbiol 1978;7:223-31.
30. Saphir DA, Carter GR. Gingival flora of the dog with special reference to bacteria associated with bites. J Clin Microbiol 1976;3:344-9.
31. Ganiere JP, Escande F, Andre G, Larrat M. Characterization of Pasteurella from gingival scrapings of dogs and cats. Comp Immunol Microbiol Infect Dis 1993;16:77-85.
32. Escande F, Lion C. Epidemiology of human infections by Pasteurella and related groups in France. Int J Med Microbiol Virol Parasitol Infect Dis 1993;297:131-9.
33. Holst E, Rollof J, Larsson L, Nielsen JP. Characterization and distribution of Pasteurella species recovered from infected humans. J Clin Microbiol 1992;30:2984-7.
34. Mutters R, Ihm P, Pohl S, Fredericksen W, Mannheim W. Reclassification of the genus Pasteurella Trevisan 1887 on the basis of deoxyribonucleic acid homology, with proposals for the new species Pasteurella dogmatis, Pasteurella canis, Pasteurella stomatis, Pasteurella anatis and Pasteurella langaa. Int J Syst Bacteriol 1985;35:309-22.
35. Biberstein EL, Spencer SJ, Kass PH, Hirsh DC. Distribution of indole-producing urease-negative pasteurellas in animals. J Vet Diagn Invest 1991; 3:319-23.
36. Segers P, Mannheim W, Vancanneyt M, et al. Reimerella anatipestifer gen. nov., comb. nov., the causative agent of septicemia anserum exsudativa, and its phylogenetic affiliation with the Flavobacterium-Cytophaga rRNA homology group. Int J Syst Bacteriol 1993;43:768-76.
37. Goldstein EJC, Citron DM. Comparative activities of cefuroxime, amoxicillin-clavulanic acid, ciprofloxacin, enoxacin, and ofloxacin against aerobic and anaerobic bacteria isolated from bite wounds. Antimicrob Agents Chemother 1988;32:1143-8.
38. Goldstein EJC, Citron DM, Richwald GA. Lack of in vitro efficacy of oral forms of certain cephalosporins, erythromycin, and oxacillin against Pasteurella multocida. Antimicrob Agents Chemother 1988;32:213-5.
39. Goldstein EJ, Citron DM. Comparative susceptibilities of 173 aerobic and anaerobic bite wound isolates to sparfloxacin, temafloxacin, clarith romycin, and older agents. Antimicrob Agents Chemother 1993;37:1150-3.
40. Goldstein EJ, Nesbit CA, Citron DM. Comparative in vitro activities of azithromycin, Bay y 3118, levofloxacin, sparfloxacin, and 11 other oral antimicrobial agents against 194 aerobic and anaerobic bite wound isolates. Antimicrob Agents Chemother 1995;39:1097-100.
41. Goldstein EJC, Citron DM, Hudspeth M, Gerardo SH, Merriam CV. In vitro activity of BAY 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humans. Antimicrob Agents Chemother 1997; 41:1552-7.
42. Goldstein EJC, Citron DM, Gerardo SH, Hudspeth M, Merriam CV. Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft rissue infections in humans. Antimicrob Agents Chemother 1998;42:1127-32.
43. Goldstein EJC, Citron DM, Hudspeth M, Gerardo SH, Merriam CV Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogens. J Antimicrob Chemother 1998;41:391-6.